Visualizing Why TSA Technology Outperforms Traditional IHC/IF Through Experimental Images

Multiple control experiments have intuitively confirmed the core shortcoming of traditional methods: two conventional approaches—direct fluorophore-conjugated secondary antibodies and streptavidin-direct fluorescence labeling—can only detect signals from highly expressed targets. For low-abundance, weakly expressed target proteins such as tissue microvessels, traditional methods completely lose signal, easily causing false-negative results that seriously affect the authenticity of experimental data.

In contrast, the TSA signal amplification system demonstrates absolute advantages: relying on HRP-catalyzed tyramide fluorogenic substrate to specifically deposit at antigen sites, achieving precise cascade signal amplification. In control experiments using the same mouse embryonic tissue and CD31 target, only TSA technology can clearly capture the weak specific signals of low-expressing microvessels. The signal hierarchy in high-expression regions is also clearer, with no additional non-specific background. This confirms that TSA is a reliable technology for stably detecting low-abundance targets, perfectly solving the defect of traditional technologies where "strong signals are visible, but weak signals are completely lost."

Traditional IHC/IF multi-labeling has significant drawbacks in immune cell typing research: multi-target staining tends to produce signal overlap and blurred boundaries, making it impossible to accurately distinguish different T cell subsets or clearly verify marker co-expression relationships, thus failing to meet the refined research needs of immune microenvironment and cell typing.

Multi-color staining results in human spleen tissue directly validate the multi-labeling advantages of TSA: through the TSA multiplex fluorescence system, triple-marker simultaneous staining of CD3, CD4, and CD8 was successfully achieved. The results clearly distinguish two mutually exclusive T cell subsets (CD4+ and CD8+), while precisely verifying that both subsets co-express the universal T cell marker CD3. Cell boundaries are clear, signals show no crosstalk, and the negative background is clean. Compared with the blurry multi-labeling effect of traditional technologies, TSA enables precise immune cell typing, target co-localization, and cell distribution analysis, adapting to various immune mechanism studies.

This is a critical pain point easily overlooked in traditional multi-label staining: mouse immune tissues (spleen) are rich in plasma cells, which highly express immunoglobulins. When using traditional staining methods, secondary antibodies will non-specifically bind to endogenous Ig in plasma cells, producing a large number of false-positive signals. Even with isotype controls or blank controls, non-specific staining persists, seriously interfering with the interpretation of real target signals and easily leading to misjudgment of experimental conclusions.

In contrast, the optimized TSA staining system, through precise site blocking and iterative staining procedures, minimizes the non-specific background caused by plasma cells. In the same mouse spleen tissue staining experiment, the TSA system can effectively distinguish real target signals from plasma cell false signals, significantly reducing the non-specific staining problem caused by endogenous immunoglobulins. This makes in-situ tissue staining results purer and interpretation more accurate—a key optimization unattainable by traditional staining systems.

Traditional IHC can only achieve dual-color labeling at most. Conventional IF exhibits severe spectral crosstalk, signal attenuation, and background elevation when performing three or more labels, completely failing to meet the needs of simultaneous detection of multiple markers in the tumor microenvironment. Researchers have to stain multiple sections separately and splice data, leading to significant experimental errors.

Staining results in human renal tumor tissue confirm the super multi-labeling potential of TSA: successful four-color simultaneous fluorescence staining of CD31, Vimentin, E-Cad, and PCNA was achieved, marking four core targets—vascular endothelium, stromal cells, epithelial cells, and proliferating cells respectively. Each marker signal is independent with no overlap or crosstalk, and specificity is extremely strong. Multiple key information including tumor proliferation, epithelial-mesenchymal transition, angiogenesis, and tissue structure distribution can be simultaneously analyzed on a single tissue section. Compared with traditional technologies, TSA significantly improves single-sample data utilization and is a core tool for tumor multi-omics and microenvironment research.

Traditional IF/IHC multi-labeling has a strict rule: same-species primary antibodies are strictly prohibited from being used together. Multiple homologous antibodies combined will cause severe cross-reactions and whole-slide background contamination, so experiments must forcibly use different-species antibodies. However, many highly specific, gold-standard antibodies only come from a single species source, greatly limiting experimental design. Many studies cannot be conducted due to the lack of suitable heterologous antibodies.

In contrast, TSA's unique site saturation blocking and step-by-step iterative staining technology completely breaks this industry barrier. Multiple control experiments successfully achieved two sets of classic same-species antibody multi-labeling: three rabbit-derived antibodies (VASA, Ki67, Laminin) used together in mouse ovarian tissue, and two mouse-derived antibodies (N-Cad, E-Cad) used together in mouse liver tissue. Staining results showed no cross-reactions, no signal interference, precise target localization, and were completely consistent with single-label staining results. This truly achieves "unlimited species, arbitrary combination," completely solving the problem of high-quality antibody compatibility.

Traditional staining technologies have extremely poor adaptability to complex embryonic tissues: embryonic tissue structures are delicate, antigens are easily lost, and cells are dense. Conventional staining easily produces problems such as messy signals, target loss, and excessive non-specific background, making it difficult to achieve simultaneous analysis of multiple structures and targets, which severely limits developmental biology research.

Multi-color staining results of E13.5 mouse embryos comprehensively confirm the broad adaptability of TSA: on the same embryonic paraffin section, simultaneous staining of multiple target types and tissue structures—including vascular endothelium, lymphatic vessels, epithelial cells, proliferating cells, and stromal cells—can be completed, clearly outlining the fine structures and cell proliferation and differentiation characteristics of different organs such as embryonic liver, kidney, lung, cochlea, and midgut. Whether for multi-species, multi-tissue, or complex embryonic samples, TSA can stably output high-definition, specific, and quantifiable staining results, with far superior versatility and stability compared to traditional IHC/IF.